Effect of diet on the microbiota and immune system in patients with systemic lupus erythematosus

被引:1
|
作者
Ruiz-Pozo, Viviana A. [1 ]
Paz-Cruz, Elius [1 ]
Cadena-Ullauri, Santiago [1 ]
Tamayo-Trujillo, Rafael [1 ]
Guevara-Ramirez, Patricia [1 ]
Simancas-Racines, Daniel [2 ]
Frias-Toral, Evelyn [3 ]
Zambrano, Ana Karina [1 ]
机构
[1] Univ UTE, Fac Ciencias Salud Eugenio Espejo, Ctr Invest Genet & Genom, Ave Mariscal Sucre & Mariana Jesus,Block 1, Quito 170129, Ecuador
[2] Univ UTE, Ctr Invest Salud Publ & Epidemiol Clin CISPEC, Quito, Ecuador
[3] Univ Espiritu Santo, Escuela Med, Samborondon, Ecuador
关键词
Systemic lupus erythematosus; gut microbiota; dysbiosis; diet; inflammation; autoimmune disease; GUT MICROBIOTA; IN-VITRO; INFLAMMATION; POLYPHENOLS;
D O I
10.1080/09540105.2024.2434475
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by widespread inflammation and organ damage. Studies indicate that diet significantly influences the gut microbiota, which, in turn, affects the immune system. This article explores gut microbiota dysbiosis in SLE patients and potential mechanisms related to dietary interventions and immune function. It highlights specific dietary patterns, such as a high-fibre diet and the Mediterranean diet, that may modulate the diversity and activity of the gut microbiota. The interaction between altered microbiota and immune responses, including the regulation of inflammatory cytokines, intestinal barrier permeability, and autoantibody production is examined. This review highlights the importance of personalized dietary strategies to modulate the diversity and activity of the gut microbiota by enhancing the immune response and potentially mitigating disease progression.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] SERUM INHIBITOR OF IMMUNE REGULATION IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    TWOMEY, JJ
    LAUGHTER, AH
    STEINBERG, AD
    JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (03): : 713 - 715
  • [42] OCULAR IMMUNE REACTANTS IN PATIENTS DYING WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    KARPIK, AG
    SCHWARTZ, MM
    DICKEY, LE
    STREETEN, BW
    ROBERTS, JL
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1985, 35 (03): : 295 - 312
  • [43] The evaluation of cellular immune function in elderly patients with systemic lupus erythematosus
    Men, Kun
    Chen, Yu
    Zhang, Jingwei
    Wei, Dianjun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 932 - 937
  • [44] ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus
    Blazer, Ashira D.
    Clancy, Robert M.
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (03)
  • [45] Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia
    Ahn, Soo Min
    Choi, Eun-Ji
    Oh, Ji Seon
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [46] ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus
    Ashira D. Blazer
    Robert M. Clancy
    Current Rheumatology Reports, 2017, 19
  • [47] Immune response to DNA in systemic lupus erythematosus
    Pisetsky, DS
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (11): : 850 - 853
  • [48] Immune Cell Metabolism in Systemic Lupus Erythematosus
    Seung-Chul Choi
    Anton A. Titov
    Ramya Sivakumar
    Wei Li
    Laurence Morel
    Current Rheumatology Reports, 2016, 18
  • [49] Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus
    Nakayamada, Shingo
    Tanaka, Yoshiya
    BIOMOLECULES, 2023, 13 (06)
  • [50] Complement, immune complexes and systemic lupus erythematosus
    Davies, KA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (01): : 5 - 23